Collaborative Multi-institutional Experience in Comparing PD-L1 Immunohistochemistry Assays: Concordance of SP142 and 22C3 Immunoreactivity

被引：3
|
作者：
Karim, Lina Abdul [1 ]
Kallakury, Bhaskar V. S. [1 ]
Chahine, Joeffrey J. [1 ]
Sheehan, Christine E. [2 ]
Ross, Jeffrey S. [2 ,3 ]
机构：
[1] Medstar Georgetown Univ Hosp NW, Dept Pathol & Lab Med, Washington, DC 20057 USA
[2] Albany Med Coll, Dept Pathol, Albany, NY 12208 USA
[3] Fdn Med Inc, Cambridge, MA USA
来源：
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 2018年 / 26卷 / 02期
关键词：
D O I：
10.1097/PAI.0000000000000609
中图分类号：
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号：
100101 ;
摘要：
引用
收藏
页码：E22 / E22
页数：1
相关论文
共 50 条
  • [41] SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
    Pang, Jia-Min B.
    Castles, Belinda
    Byrne, David J.
    Button, Peter
    Hendry, Shona
    Lakhani, Sunil R.
    Sivasubramaniam, Vanathi
    Cooper, Wendy A.
    Armes, Jane
    Millar, Ewan K. A.
    Raymond, Wendy
    Roberts-Thomson, Samuel
    Kumar, Beena
    Burr, Marian
    Selinger, Christina
    Harvey, Kate
    Chan, Charles
    Beith, Jane
    Clouston, David
    O'Toole, Sandra A.
    Fox, Stephen B.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (08) : 1108 - 1117
  • [42] Pitfalls of PD-L1 Immunohistochemistry: A Comparison of 22C3 and SP263 antibodies Across Laboratories and Pathologists
    Wilberger, Adam
    Aisner, Dara
    Merrick, Daniel T.
    LABORATORY INVESTIGATION, 2018, 98 : 756 - 757
  • [43] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Cha, Yoon Jin
    Kim, Dooreh
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Lee, Hye Sun
    Jeon, Soyoung
    Yoo, Tae-Kyung
    Park, Woo-Chan
    Yoon, Chang Ik
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Routine PD-L1 Immunohistochemistry Testing by 22C3 in a Canadian Reference Testing Center
    Albaqer, T.
    Santiago, R.
    Leung, Y.
    Pal, P.
    Khan, Z.
    Torlakovic, E.
    Cheung, C.
    Hwang, D.
    Tsao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2003 - S2003
  • [45] Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on Surgical Specimens of NSCLC
    Saito, T.
    Tsuta, K.
    Ishida, M.
    Ryota, H.
    Takeyasu, Y.
    Fukumoto, K.
    Matsui, H.
    Taniguchi, Y.
    Yanagimoto, H.
    Yokoi, T.
    Kurata, T.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1816 - S1817
  • [46] PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays
    Dabbagh, Tamara Z.
    Sughayer, Maher A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (06) : 462 - 466
  • [47] External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different
    Dodson, Andrew
    Parry, Suzanne
    Lissenberg-Witte, Birgit
    Haragan, Alex
    Allen, David
    O'Grady, Anthony
    McClean, Emma
    Hughes, Jamie
    Miller, Keith
    Thunnissen, Erik
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02): : 138 - 145
  • [48] Evaluation of concordance between PD-L1 immunohistochemistry 28-8 and 22C3 pharmDx assays in metastatic urothelial carcinoma (mUC) in PIVOT-10
    Siefker-Radtke, A. O.
    Hoch, U.
    Loriot, Y.
    Balar, A. V.
    Bilen, M. A.
    Tannir, N. M.
    Cho, D. C.
    Choudhury, A.
    Chien, D.
    Yu, D.
    Currie, S. L.
    Novotny, J.
    Santiago, L.
    Tagliaferri, M. A.
    Zalevsky, J.
    Huddart, R. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S392 - S393
  • [49] Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study
    Zaakouk, Mohamed
    Van Bockstal, Mieke
    Galant, Christine
    Callagy, Grace
    Provenzano, Elena
    Hunt, Roger
    D'Arrigo, Corrado
    Badr, Nahla M.
    O'Sullivan, Brendan
    Starczynski, Jane
    Tanchel, Bruce
    Mir, Yasmeen
    Lewis, Paul
    Shaaban, Abeer M.
    CANCERS, 2023, 15 (05)
  • [50] Concordance of Surgical Resections and Fine Needle Biopsy-Derived Cell Block Sections for PD-L1 22C3 Immunohistochemistry
    Schwock, J.
    Ko, H. M.
    Weiss, J.
    Cheung, C.
    Boerner, S.
    Tsao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S957 - S958
12345